While Petridou et al. reported that endometrial cancer was positively associated with serum levels of IGF2 and inversely associated with IGF1 [36], our study did not establish a significant correlation between IGF levels and endometrial cancer risk. The gene discussed is IGF2; the disease is endometrial cancer.